ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,133Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 2343

$892K Total Retail Price of All Prescriptions

Rank: 186 out of 2343

497 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 19,939 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 1,170 1,160 1 2
FUROSEMIDE 833 833 2 6
JANTOVEN 769 769 3 81
CITALOPRAM HBR 670 670 4 17
OMEPRAZOLE 659 633 5 4
SIMVASTATIN 526 524 6 1
AMLODIPINE BESYLATE 523 516 7 5
DONEPEZIL HCL 518 518 8 21
METOPROLOL TARTRATE 483 483 9 7
ATENOLOL 398 396 10 12
LISINOPRIL 367 367 11 3
SPIRONOLACTONE 357 357 12 65
POLYETHYLENE GLYCOL 3350 356 350 13 54
PANTOPRAZOLE SODIUM 343 343 14 22
HYDROCODONE-ACETAMINOPHEN 331 313 S3 15 13
KLOR-CON M10 325 325 16 107
NAMENDA 300 300 17 36
DIGOXIN 261 261 18 35
MIRTAZAPINE 257 257 19 41
WARFARIN SODIUM 232 232 20 8
QUETIAPINE FUMARATE 228 228 21 77
ATORVASTATIN CALCIUM 217 211 22 10
CARVEDILOL 216 216 23 27
TAMSULOSIN HCL 197 197 24 29
CARBIDOPA-LEVODOPA 196 196 25 85
SERTRALINE HCL 194 194 26 20
ISOSORBIDE MONONITRATE ER 181 181 27 32
ENALAPRIL MALEATE 180 175 28 58
KLOR-CON M20 161 150 29 44
POTASSIUM CHLORIDE 153 153 30 18
TRAZODONE HCL 153 153 30 53
DILTIAZEM 24HR CD 142 142 32 83
GABAPENTIN 142 142 32 16
LANTUS 138 138 34 51
NOVOLOG 133 133 35 110
CLOPIDOGREL 129 129 36 26
ESCITALOPRAM OXALATE 120 120 37 55
EXELON 119 119 38 129
PREDNISONE 112 112 39 37
LANSOPRAZOLE 112 112 39 162
PRAVASTATIN SODIUM 103 100 41 15
GLIPIZIDE 102 102 42 56
DIOVAN 94 94 43 23
FINASTERIDE 92 92 44 80
NEXIUM 90 80 45 33
TRAMADOL HCL 88 88 46 25
SEROQUEL 88 88 46 171
METOPROLOL SUCCINATE 83 83 48 14
NITROGLYCERIN PATCH 83 83 48 147
PLAVIX 83 83 48 38
ROPINIROLE HCL 82 70 51 124
OXYCODONE HCL 81 81 S2 52 67
ACTONEL 81 81 52 182
HUMALOG 81 81 52 131
FENTANYL 80 80 S2 55 69
PRANDIN 79 79 56 140
LEVETIRACETAM 78 78 57 104
AZITHROMYCIN 77 75 58 39
OXYCONTIN 75 75 S2 59 138
LORAZEPAM 75 75 59 210
ALENDRONATE SODIUM 72 72 61 28
DILTIAZEM HCL 71 71 62 276
ALBUTEROL SULFATE 68 68 63 126
DOXAZOSIN MESYLATE 67 67 64 98
ADVAIR DISKUS 66 66 65 34
PHENYTOIN SODIUM EXTENDED 66 66 65 152
JANUVIA 66 66 65 50
SOTALOL 64 64 68 177
CIPROFLOXACIN HCL 63 63 69 72
AMOXICILLIN 62 62 70 118
METFORMIN HCL 59 52 71 9
CEPHALEXIN 59 59 71 111
RISPERIDONE 59 59 71 61
BETHANECHOL CHLORIDE 58 58 74 349
RESTASIS 53 53 75 450
BENICAR 53 53 75 93
DETROL LA 53 53 75 150
CELEBREX 53 53 75 71
VENLAFAXINE HCL ER 50 49 79 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.